Monensin (lOnM-l pM) 
Cartilage proteoglycans are complex macromolecules in which many glycosaminoglycan chains are attached to a protein core. Chondrocytes isolated from the Swarm rat chondrosarcoma have been shown to produce cartilage-type proteoglycans in culture. The proteoglycans are secreted from the cells as monomers, but form aggregates in the culture medium by binding to hyaluronate and a specific link protein (Kimura et al., 1979) . All three components of the aggregate are synthesized by the chondrocytes, but it remains to be determined how aggregation is delayed until the components have been secreted from the cells (Hardingham, 1981; Kimura et al., 198 ib) . Experiments suggest that link protein may be secreted already bound to the proteoglycan (Kimura et al., 1980) , but the pathways of synthesis and secretion of hyaluronate remain unknown. The post-translational modifications of the proteoglycan protein core, which involve the initiation, elongation and sulphation of the chondroitin sulphate chains, occur primarily in the Golgi region of the cell, and with chick chondrocytes it has been shown that monensin is a potent inhibitor of chondroitin sulphate synthesis and sulphation (Tajiri et al., 1980) . Monensin is a carboxylic ionophore that interferes with the intracellular pathways of secretory proteins in many different cell types (Tartakoff & Vassalli, 1977 Uchida et al., 1979) . It causes a rapid dilation of the Golgi elements, which may result from partial Na+/K+ equilibration across the membranes (Tartakoff & Vassalli, 1978) . The present study examines further the effects of monensin on proteoglycan and hyaluronate synthesis in chondrocytes. 
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Materials and methods
Materials were obtained as previously described (Mitchell & Hardingham, 1981 [35S]Sulphate-labelled macromolecules were determined by extraction in 1% (w/v) Zwittergent/ 2 M-guanidine hydrochloride and chromatography on columns of Sephadex G-50, as described in Fig.  1 . The incorporation into [3Hlglucosamine-labelled macromolecules was determined after alkali elimination and Sephadex G-50 chromatography, as described in Fig. 4 .
Assay methods
Hexuronic acid was determined by an automated procedure (Heinegard, 1973) of the modified (Bitter & Muir, 1962) 4°C for 1 h. Previous experiments showed that 2 M-guanidine released pericellular material, but Zwittergent was required to release intracellular labelled macromolecules (Kimura et al., 198 la; Mitchell, 1981) . The total incorporation was determined after chromatographing the medium, pericellular extract and cell extract on columns (25 cm x 0.8 cm) of Sephadex G-50 in 4M-guanidine hydrochloride to remove unincorporated label (Kimura et al., 1979 3.5% in proteoglycan). There was excellent agreement of these results with other similar experiments on monensin inhibition with incubation times from 2 to 6 h, some with dual labelling (Mitchell, 1981) .
The effect of monensin on secretion was assessed by measuring the distribution of 35S-labelled macromolecules between cell and medium fractions. The secretion of 35S-labelled macromolecules into the medium was inhibited by monensin, but by only 52% when the total incorporation of [35Slsulphate was inhibited by 92.4% (Fig. 2a) . Sulphation was thus much more sensitive to monensin than was secretion, as reported by Tajiri et al. (1980) . With [3Hlglucosamine (Fig. 2b) Schwartz, 1975) . The total rate of chain synthesis is thus enhanced, as it is no longer limited by the availability of acceptor sites on proteoglycan protein core (Mitchell & Hardingham, 1982) . The rate of chondroitin sulphate synthesis in the presence of p-nitrophenyl f3-D-xyloside is thus a measure of capacity of the chondroitin sulphate-synthesizing enzymes (Schwartz, 1977 
Effect ofmonensin on the size ofproteoglycans
The proteoglycans synthesized in the presence of monensin were extracted from the cultures in 2M-guanidine hydrochloride/1% (w/v) Zwittergent and the sizes were compared by gel chromatography on Sepharose CL-2B under dissociative conditions (Fig. 3) . At low extents of inhibition the size of the monomer did not appear to change, but with inhibition above 50% the average size became progressively smaller. Fewer proteoglycans were oligosaccharides. Carrier chondroitin sulphate (1 mg/extract) was added to the pooled V0 fractions, which were then dialysed and freeze-dried. Samples dissolved in 0.5M-sodium acetate, pH6.8, were chromatographed on a column (143cm x 0.9 cm) of Sepharose CL-6B in 0.5 M-sodium acetate, pH 6.8, before (a-f) and after (g-l) digestion with Streptomyces hyaluronidase. Fractions (1 ml) were collected and the radioactivity was determined. The digestion was carried out in 0.1 M-sodium acetate/0. 15 M-NaCl (pH 7.1) for 20h at 37°C with 2.5 turbidity-reducing units of enzyme/mg of uronic acid in the sample. Columns (f) and (I) were loaded with samples prepared from twice the volume of extract as for those applied to the other columns. For determining [35Slsulphate incorporation, parallel cultures were incubated with [35Slsulphate (lOpuCi/ml) for 360min. The radioactivity excluded from Sephadex 0-50 columns was determined in an extract of the medium and cell layer in 1% Zwittergent/2 M-guanidine hydrochloride prepared as in Fig. 3 . Values in parentheses show the radioactivity in hyaluronate (hatched area) as a percentage of the total incorporation of 13Hlglucosamine in control cultures.
thus being synthesized in the presence of monensin, Effiects of monensin on synthesis of hyaluronate and and they were of smaller average size, and this may chondroitin sulphate have resulted from both decreased sulphation and Cultures incubated with [3Hlglucosamine for 6 h shorter chondroitin sulphate chains, were extracted in0.5 M-NaOH at 4°Cfor 18 hto release by fl-elimination all of the chondroitin sulphate chains. The extract from the control culture showed an elution profile of a small excluded peak of hyaluronate (Fig. 4a) , that was digested by the Streptomyces hyaluronidase (Fig. 4g) , and a retarded chondroitin sulphate peak. As the concentration of monensin increased, the proportion of radioactivity in the chondroitin sulphate peak decreased, and it appeared more polydisperse (Figs. 4d, 4e and 4f), but the amount of radioactivity in the hyaluronate peak did not change compared with the control cultures. Hyaluronate synthesis was thus not inhibited even by 1 pM-monensin, which gave 98% inhibition of [35Slsulphate incorporation, 80% inhibition of 13Hlglucosamine incorporation and 53% inhibition of protein synthesis (Fig. 1 ).
Discussion
The results showed that the sulphation of chondroitin sulphate was particularly sensitive to inhibition by monensin. The secretion of proteoglycan was also inhibited by monensin, but only at concentrations that severely inhibited its synthesis, and even at higher concentrations inhibition was not complete. These results are comparable with those reported by Tajiri et al. (1980) with chick chondrocytes, who also showed much less effect on proteoglycan secretion than on procollagen secretion, which was inhibited and led to its accumulation in the cells. This may imply that the block in secretion observed with other proteins occurs at a stage in intracellular migration before the location of chondroitin sulphate synthesis on proteoglycans is reached. Proteoglycan protein core devoid of chondroitin sulphate chains may thus have accumulated before the site of chondroitin sulphate synthesis, but it would not have been detected by the techniques used in the present study.
Previous results (Mitchell & Hardingham, 1981 , 1982 Mitchell, 1981; Kimura et al., 198 la) showed there to be an inverse correlation between the rate of chondroitin sulphate synthesis in these chondrocyte cultures and the length of the chains synthesized. Inhibition of proteoglycan protein-core synthesis with cycloheximide thus led to fewer, longer chondroitin sulphate chains being synthesized, whereas stimulation of synthesis with p-nitrophenyl fl-D-xyloside led to more, shorter chains being formed. The chain length of chondroitin sulphate thus appeared to be related to the ratio of chainsynthesizing-enzyme activity to acceptor concentration. The failure of added xyloside to relieve inhibition suggests that monensin's major effect is to decrease the chain-synthesizing-enzyme activity, by, for example, disrupting membrane-associated enzymes or their supply of nucleotide sugar substrates, although it may also affect the availability of the acceptor. The results observed with monensin thus follow a different pattern from those with cycloheximide or xyloside, as the decrease in chondroitin sulphate synthesis is accompanied by a decrease in the average size of the chains.
The synthesis of proteoglycans is believed to follow the pathway of other newly synthesized proteins that are destined for secretion, involving synthesis into the internal compartments of the endoplasmic reticulum, movement within these compartments or within vacuoles to the Golgi lamella, before migration within vacuoles to the outer cell membrane for secretion (Palade, 1975) . As carbohydrate groups of many different types are added to the proteins at different stages of this pathway and these additions require high-energy metabolic intermediates, there must be mechanisms for transferring these components from the cytosol into the membrane-bound compartments. One of the effects of monensin may thus be to perturb the mechanisms of this energy transfer. For proteoglycan synthesis it could particularly affect (a) phosphoadenosine 5'-phosphosulphate production, which is required for sulphation, and (b) and supply of nucleotide sugars for chondroitin sulphate chain elongation.
The failure of monensin to inhibit hyaluronate synthesis has several important implications. It suggests that hyaluronate is synthesized within a different compartment from chondroitin sulphate, as previously suggested by Kleine (1978) , and at this location it is insensitive to monensin effects on membranes. The continuation of hyaluronate synthesis shows that UDP-glucuronic acid and UDP-N-acetylglucosamine are available at this site of synthesis, which thus may be outside the membranous compartments of the endoplasmic reticulum. It remains unknown how hyaluronate biosynthesis is initiated, but it does not seem to be made as a proteoglycan, as its biosynthesis is not inhibited by cycloheximide at concentrations that inhibit proteoglycan synthesis (Mitchell, 1981) . A site of synthesis remote from the pathways followed by normal secretory proteins is thus not ruled out, and the intracellular separation of hyaluronate synthesis from proteoglycan and link-protein synthesis could explain why the interaction between these components to form proteoglycan aggregates is delayed until after secretion from the cell.
